Biodesix to participate in william blair's 43rd annual growth stock conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that scott hutton, chief executive officer of biodesix, will present and host in-person 1x1 investor meetings at william blair's 43rd annual growth stock conference, which will be held from june 6-8, 2023. william blair's 43rd annual growth stock conference presentation date: wednesday, june 7, 2023 presentation time: 4:40 pm ct locatio.
BDSX Ratings Summary
BDSX Quant Ranking